Comparison of mouse and rabbit model for the assessment of strong PGM-containing oil-based adjuvants

Veterinary Immunology and Immunopathology

Volumn 121, Issue 3-4, 2008, Pages 232-240

  Habjanec, Lidija ^a   Halassy, Beata ^a   Vdović, Valerija ^a   Balija, Maja Lang ^a   Tomašić, Jelka ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

ISA adjuvants; Mice; Peptidoglycan monomer; Rabbits

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; MONOMER; MONTANIDE ISA 206; MONTANIDE ISA 720; OIL; OVALBUMIN; PEPTIDOGLYCAN MONOMER; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; RABBIT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; MANNITOL; MICE; MICE, INBRED CBA; MODELS, ANIMAL; OLEIC ACIDS; OVALBUMIN; PEPTIDOGLYCAN; RABBITS; SNAKE VENOMS; STATISTICS, NONPARAMETRIC;

MAMMALIA; MUS; ORYCTOLAGUS CUNICULUS;

EID: 38749096634     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.09.014     Document Type: Article

References (25)

1. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L.S.M., Pollock B., and Pye D. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16 (1998) 240-247
2. Cox S.J., Aggarwal N., Statham R.J., and Barnett P.V. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21 (2003) 1336-1347
3. Dutta S., Ware L.A., Barbosa A., Ockenhouse C.F., and Lanar D.E. Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Infect. Immun. 69 (2001) 5464-5470
4. Edelman R. An overview of adjuvant use. In: O'Hagan D.T. (Ed). Vaccine adjuvants: Preparation Methods and Research Protocols, Methods in Molecular Medicine vol. 42 (2000), Humana Press, Inc., Totowa, New Jersey 1-27
5. Habjanec L., Frkanec R., Halassy B., and Tomašić J. Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice. J. Liposome Res. 16 (2006) 1-16
6. Halassy B., Krstanović M., Frkanec R., and Tomašić J. Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine 21 (2003) 971-976
7. Halassy B., Habjanec L., and Tomašić J. Peptidoglycan monomer-product of biotechnology with immunomodulatory properties. In: Kniewald Z. (Ed). Immuno-Modulatory Drugs. Current Studies of Biotechnology vol. IV (2005), Croatian Society of Biotechnology and Medicinska Naklada, Zagreb 137-143
8. Halassy B., Mateljak S., Bouche F.B., Pütz M.M., Muller C.P., Frkanec R., Habjanec L., and Tomašić J. Immunogenicity of peptides of measles virus origin and influence of adjuvants. Vaccine 24 (2006) 85-94
9. Halassy B., Vdović V., Habjanec L., Lang Balija M., Gebauer B., Sabioncello A., Šantek T., and Tomašić J. Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits. Vaccine 25 (2007) 3475-3481
10. Halassy Špoljar B., Čimbora T., Hanzl-Dujmović I., Dojnović B., Sabioncello A., Krstanović M., and Tomašić J. Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice. Vaccine 20 (2002) 3543-3550
11. 19) formulated in oil-based Montanides. Vaccine 21 (2003) 2923-2932
12. Johansson J., Ledin A., Vernersson M., Lövgren-Bengtsson K., and Hellman L. Identification of adjuvants that enhance the therapeutic antibody response to host IgE. Vaccine 22 (2004) 2873-2880
13. Keglević D., Ladešić B., Tomašić J., Valinger Z., and Naumski R. Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim. Biophys. Acta 585 (1979) 273-281
14. Krstanović M., Frkanec R., Vranešić B., Ljevaković D., Šporec V., and Tomašić J. Reversed-phase high-performance liquid chromatographic method for the determination of peptidoglycan monomers and structurally related peptides and adamantyltripeptides. J. Chromatogr. B 773 (2002) 167-174
15. Lang Balija, M., 2002. Immune reaction specific for venom of long-nosed viper (Vipera ammodytes) in mice and influence of adjuvants. Master of Science Thesis, Zagreb (in Croatian).
16. Ljevaković D., Tomašić J., Šporec V., Halassy Špoljar B., and Hanzl-Dujmović I. Synthesis of novel adamatylacetyl derivate of peptidoglycan monomer-biological evaluation of immunomodulatory peptidoglycan monomer and respective derivates with lipophilic substituents on amino group. Bioorg. Med. Chem. 8 (2000) 2441-2449
17. Mateljak Lukačević, S., 2005. Immunogenicity of synthetic peptides comprising T- and B-epitopes of measles virus origin and influence of peptidoglycan monomer (PGM) as adjuvant. Master of Science Thesis, Zagreb (in Croatian).
18. Sachdeva S., Ahmad G., Malhotra P., Mukherjee P., and Chauhan V.S. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kilodalton fragments expressed in Escherichia coli. Vaccine 72 (2004) 5775-5782
19. Stewart-Tull D.E.S. The assessment and use of adjuvants. In: Gregoriadis G., et al. (Ed). Vaccines (1991), Plenum Press, New York 85-92
20. Stewart-Tull D.E.S. Recommendations for the assessment of adjuvants (immunopotentiators). In: Gregoriadis G., Allison A.C., and Poste G. (Eds). Immunological Adjuvants and Vaccines (1991), Plenum Publishing Corporation, New York 213-226
21. 14C-labeled peptidoglycan monomer in mice, I. Indentification of the monomer and the corresponding pentapeptide in urine. Biochim. Biophys. Acta 629 (1980) 77-82
22. Tomašić J., Valinger Z., Hršak I., and Ladešić B. Metabolic fate of peptidoglycan monomer from Brevibacterium divaricatum and biological activity of its metabolites. In: Seidl P.H., and Schleifer K.H. (Eds). Biological Properties of Peptidoglycans (1986), Walter de Gruyter & Co., Berlin 203-208
23. Tomašić J., and Hršak I. Peptidoglycan monomer originating from Brevibacterium divaricatum-its metabolism and biological activities in the host. In: Schrinner E., Richmond M.H., Seibert G., and Schwarz U. (Eds). Surface Structures of Microorganisms and their Interactions with the Mammalian Host (1987), VCH, Weinheim 113-121
24. Tomašić J., Hanzl-Dujmović I., Špoljar B., Vranešić B., Šantak M., and Jovičić A. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Vaccine 18 (2000) 1236-1243
25. Wright S.P. Adjusted P-values for simultaneous inference. Biometrics 27 (1992) 77-81